Price loading...

The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in Japan

Price data last checked 94 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
08 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in Japan
99% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in Japan
98% match

The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in Japan

£495.00 16 Dec 2025
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan

£495.00 08 Feb 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan

£495.00 19 Apr 2026
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in Japan
96% match

The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for Motion Sickness Medications in Japan
96% match

The 2023-2028 Outlook for Motion Sickness Medications in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Over the Counter Drugs in Japan
96% match

The 2023-2028 Outlook for Over the Counter Drugs in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for Motion Sickness Treatments in Japan
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in Japan

£495.00 11 Mar 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in Japan
96% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan
95% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for OTC Drugs in Japan
95% match

The 2023-2028 Outlook for OTC Drugs in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan
95% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan
95% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan

£495.00 09 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
95% match

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

£495.00 10 Jan 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan
95% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan

£495.00 25 Jan 2026
The 2023-2028 Outlook for Topical Antiseptic Medications in Japan
95% match

The 2023-2028 Outlook for Topical Antiseptic Medications in Japan

£495.00 13 Dec 2025
The 2023-2028 Outlook for Pure Generic Drugs in Japan
95% match

The 2023-2028 Outlook for Pure Generic Drugs in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in Japan
95% match

The 2023-2028 Outlook for Anti-Malarial Drugs in Japan

£495.00 13 Dec 2025
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
95% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan

£495.00 26 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
95% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 24 Jan 2026
The 2023-2028 Outlook for Nocturia Drugs in Japan
95% match

The 2023-2028 Outlook for Nocturia Drugs in Japan

£495.00 20 Apr 2026
The 2023-2028 Outlook for Erythropoietin Drugs in Japan
95% match

The 2023-2028 Outlook for Erythropoietin Drugs in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Therapeutic-Protein Biological Drugs in Japan
95% match

The 2023-2028 Outlook for Therapeutic-Protein Biological Drugs in Japan

£495.00 12 Jan 2026